| 1 |
C04A |
Peripheral vasodilators (cinnarizine, nimodipine, etc.) |
196.99 |
| 2 |
N06D |
Anti-dementia drugs (piracetam, levocarnitine, etc.) |
179.56 |
| 3 |
C10A B |
Fibrates (gemfibrozil, clofibrate, etc.) |
156.26 |
| 4 |
H05B A |
Calcitonin preparations |
135.71 |
| 5 |
N05C |
Hypnotics and sedatives (temazepam, phenobarbitone, etc.) |
121.21 |
| 6 |
R05C |
Expectorants (acetylcysteine, guaifenesin, etc.) |
92.05 |
| 7 |
H01A C |
Growth hormone (somatropin) |
91.41 |
| 8 |
R03D A |
Xanthines (theophylline, aminophylline, etc.) |
85.01 |
| 9 |
A02B C |
Proton pump inhibitors (omeprazole, lansoprazole, etc.) |
82.10 |
| 10 |
R03B A |
Glucocorticoids, inhalants (beclomethasone, budesonide, etc.) |
78.80 |
| 11 |
C10A A |
HMG CoA reductase inhibitors (simvastatin, pravastatin, etc.) |
73.53 |
| 12 |
N03A |
Antiepileptics (phenytoin, carbamazepine, etc.) |
72.55 |
| 13 |
S01E |
Antiglaucoma preparations and miotics (pilocarpine, timolol, etc.) |
71.24 |
| 14 |
M05B |
Drugs affecting mineralization (alendronate, etidronate, etc.) |
68.59 |
| 15 |
R03A |
Adrenergics, inhalants (salbutamol, salmeterol, etc.) |
63.16 |
| 16 |
N04 |
Anti-Parkinson drugs (levodopa, bromocriptine, etc.) |
58.21 |
| 17 |
A07E |
Intestinal anti-inflammatory agents (sulfasalazine, mesalazine, etc.) |
56.43 |
| 18 |
A10A |
Insulins and analogues |
55.40 |
| 19 |
H03B |
Antithyroid preparations (thiamazole, propylthiouracil, etc.) |
48.83 |